Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Treated With Percutaneous Coronary Intervention - The Dan-DAPT Trial

NCT05262803 is registered in ClinicalTrials.gov with Rikke Sorensen as lead sponsor.

NCT NCT05262803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05262803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction Treated With Percutaneous Coronary Intervention - The Dan-DAPT Trial
Lead sponsor
Rikke Sorensen
Phase
Phase 4
Overall status
Recruiting
Start date
June 17, 2022
Completion date
December 31, 2028
Enrollment
2,808 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction